Jane Street
BCYC

Jane Street’s Bicycle Therapeutics BCYC Stock Holding History

Jane Street’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Sell
26,800
-58,100
-68% -$266K ﹤0.01% 10524
2026
Q1 		$394K Buy
84,900
+70,100
+474% +$401K ﹤0.01% 8584
2025
Q4 		$105K Buy
+14,800
New +$109K ﹤0.01% 10165

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Jane Street's BCYC Position: Q2 2026 in Review

Jane Street increased its Bicycle Therapeutics (BCYC) stake by 80% in Q2 2026, buying an estimated $798K and bringing the position to 392,163 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #5510.

Jane Street first reported a position in BCYC in Q4 2021 and has held it in 14 quarters since. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Jane Street held 392,163 shares of Bicycle Therapeutics worth $1.66M as of Q2 2026.
  • Jane Street bought 174,048 Bicycle Therapeutics shares in Q2 2026, an estimated $798K.
  • Bicycle Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5510 holding.
  • Jane Street first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.